A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 11/21/2018 |
| Start Date: | March 13, 2018 |
| End Date: | August 2021 |
| Contact: | Krista Rowe, RN |
| Email: | krista.rowe@duke.edu |
| Phone: | 9196847115 |
A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation
This is a research study to compare the well-being (caregiver strain index) of caregivers of
patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
patients receiving home vs standard care after autologous hematopoietic stem cell transplant.
Patient Inclusion Criteria:
- Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer
or non-cancer illness
- Age 18-80 years
- Karnofsky Performance Scale KPS> 80
- Able to read/write English
- A home that is deemed, upon inspection, in suitable condition to serve as a medical
home, within a 90-minute driving distance of Duke
Patient Exclusion Criteria:
- Lack of a caregiver
- Pregnant women
- Patients with a documented active infection prior to starting their preparative
regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
- Use of homeopathic medications, prebiotics, or probiotics that may impact gut
microbiota
Caregiver Inclusion Criteria:
- Identified by patient as their primary caregiver
- Meet standard clinical criteria for being a caregiver (able to drive and take care of
patient)
- Age 18-80 years
Caregiver Exclusion Criteria:
We found this trial at
1
site
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
